Viridian Therapeutics, Inc.\DE
2022 Q2 - 2025 Q4 (14 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 3,500 | 0.0% | 112,682 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 1,098 | 0.0% | 78,515 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 812 | 0.0% | 60,235 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 953 | 0.0% | 49,720 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 563 | 0.0% | 24,732 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 412 | 0.0% | 31,687 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 424 | 0.0% | 24,237 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 350 | 0.0% | 16,055 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 252 | 0.0% | 16,411 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 404 | 0.0% | 16,988 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 383 | 0.0% | 15,037 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 421 | 0.0% | 14,428 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 218 | 0.0% | 10,639 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 124 | 0.0% | 10,728 | 6/30/2022 |